Qiagen N.V. Press Releases https://corporate.qiagen.com/generated by Q4Fri, 05 Jun 2026 05:18:39 -0400Copyright Q4 Inc. All rights reserved.QIAGEN supports infectious disease research and surveillance efforts for Bundibugyo ebolavirus outbreak48df34ab-cac5-40cb-a561-07aec175bdbdhttps://corporate.qiagen.com/English/newsroom/press-releases/press-release-details/2026/QIAGEN-Supports-Infectious-Disease-Research-and-Surveillance-Efforts-for-Bundibugyo-Ebolavirus-Outbreak/default.aspxThu, 28 May 2026 16:05:00 -0400QIAGEN launches QIA Agent, connecting AI-driven scientific guidance across Sample to Insight workflows9dd7830f-f067-4311-aad3-e6c731c89a66https://corporate.qiagen.com/English/newsroom/press-releases/press-release-details/2026/QIAGEN-launches-QIA-Agent-connecting-AI-driven-scientific-guidance-across-Sample-to-Insight-workflows/default.aspxWed, 20 May 2026 16:05:00 -0400QIAGEN to advance AI-driven drug discovery with graph-based AI and curated bioinformatics knowledge with NVIDIA4fade969-58d5-4f76-99da-65dea8680617https://corporate.qiagen.com/English/newsroom/press-releases/press-release-details/2026/QIAGEN-to-advance-AI-driven-drug-discovery-with-graph-based-AI-and-curated-bioinformatics-knowledge-with-NVIDIA/default.aspxTue, 19 May 2026 16:05:00 -0400QIAGEN to Appoint Dr. Metin Colpan as Honorary Chairman of the Supervisory Board, Continue Governance Renewal and Propose Increased Returns at 2026 Annual General Meetingd62c8116-132a-4c32-b19c-a3959fe76631https://corporate.qiagen.com/English/newsroom/press-releases/press-release-details/2026/QIAGEN-to-Appoint-Dr--Metin-Colpan-as-Honorary-Chairman-of-the-Supervisory-Board-Continue-Governance-Renewal-and-Propose-Increased-Returns-at-2026-Annual-General-Meeting/default.aspxTue, 12 May 2026 02:00:00 -0400QIAGEN Plans to Launch New Fully Automated Sample to Insight Workflow and an AI-Enabled Risk Stratification Tool to Advance QuantiFERON Latent TB Testing62b1f5f7-9e25-4f0a-9780-ffe98b341682https://corporate.qiagen.com/English/newsroom/press-releases/press-release-details/2026/QIAGEN-Plans-to-Launch-New-Fully-Automated-Sample-to-Insight-Workflow-and-an-AI-Enabled-Risk-Stratification-Tool-to-Advance-QuantiFERON-Latent-TB-Testing/default.aspxThu, 07 May 2026 06:00:00 -0400QIAGEN Reports Full Results for Q1 2026ba8a1693-ea2f-4b13-8e0a-450ce26d209bhttps://corporate.qiagen.com/English/newsroom/press-releases/press-release-details/2026/QIAGEN-Reports-Full-Results-for-Q1-2026/default.aspxWed, 06 May 2026 16:05:00 -0400QIAGEN reports preliminary Q1 2026 results: achieves adjusted EPS outlook with mixed sales trends; updates full-year 2026 outlookf2aa604d-aa00-41bf-9bb4-7c843db2d8c3https://corporate.qiagen.com/English/newsroom/press-releases/press-release-details/2026/QIAGEN-reports-preliminary-Q1-2026-results-achieves-adjusted-EPS-outlook-with-mixed-sales-trends-updates-full-year-2026-outlook/default.aspxMon, 27 Apr 2026 16:16:00 -0400QIAGEN to Showcase New Sample to Insight Solutions for Complex Oncology Applications at AACR 202670f5c8a9-3afa-4b1f-8a4a-88ee778a2888https://corporate.qiagen.com/English/newsroom/press-releases/press-release-details/2026/QIAGEN-to-Showcase-New-Sample-to-Insight-Solutions-for-Complex-Oncology-Applications-at-AACR-2026/default.aspxThu, 16 Apr 2026 16:05:00 -0400QIAGEN Expands Into Bloodstream Infection Syndromic Testing With New Rapid QIAstat-Dx Panele9c2a6f8-3d43-40f3-b2bf-7fc0eb56a65bhttps://corporate.qiagen.com/English/newsroom/press-releases/press-release-details/2026/QIAGEN-Expands-Into-Bloodstream-Infection-Syndromic-Testing-With-New-Rapid-QIAstat-Dx-Panel/default.aspxTue, 14 Apr 2026 16:05:00 -0400QIAGEN Announces Form 20-F Annual Report Filing for 2025 Resultsd4189e49-4b1e-4ef0-bda1-7e619676c00dhttps://corporate.qiagen.com/English/newsroom/press-releases/press-release-details/2026/Qiagen-Announces-Form-20-F-Annual-Report-Filing-for-2025-Results/default.aspxFri, 20 Mar 2026 07:30:00 -0400